High-dose intravenous epoetin does not increase blood pressure in critically ill patients with acute kidney injury
Treatment of renal anemia with erythropoietic stimulating agents sometimes increases blood pressure. It is uncertain whether this is due to direct vasoconstriction and/or increased red blood cell mass. We conducted a post-hoc analysis of 160 critically ill patients in the EARLYARF trial with elevat...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dustri-Verlag
2013
|
| Subjects: | |
| Online Access: | http://irep.iium.edu.my/10623/1/1._Clinical_Nephrology_2013_EPO_%26_BP.pdf |